Aurora Financial Journal

Bavarian Nordic (BAVA.CO)

Nasdaq Copenhagen · Biotechnology · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), Bavarian Nordic reported revenue of DKK 6.24B and net income of DKK 1.38B. Annual financial statements are available for fiscal years 2021 to 2025, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

DKKFY2025
2025-12-31
FY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
FY2021
2021-12-31
Income statement
RevenueDKK 6.24BDKK 5.72BDKK 7.06BDKK 3.15BDKK 1.90B
Gross profitDKK 3.05BDKK 2.82BDKK 4.60BDKK 1.70BDKK 570.3M
Operating incomeDKK 1.80BDKK 939.8MDKK 1.50B−DKK 70.8M−DKK 313.5M
Net incomeDKK 1.38BDKK 988.0MDKK 1.48B−DKK 347.4M−DKK 464.8M
Diluted EPSDKK 17.60DKK 12.60DKK 19.20−DKK 4.90−DKK 7.40
Cash flow
Operating cash flowDKK 2.72BDKK 1.95BDKK 1.12BDKK 220.1M−DKK 358.5M
Capital expenditureDKK 205.3MDKK 82.7MDKK 142.5MDKK 361.2MDKK 483.1M
Free cash flowDKK 2.52BDKK 1.87BDKK 976.7M−DKK 141.2M−DKK 841.6M
Balance sheet
Cash and equivalentsDKK 1.71BDKK 1.62BDKK 1.48BDKK 575.4MDKK 591.8M
Total assetsDKK 14.95BDKK 14.41BDKK 14.35BDKK 12.39BDKK 12.09B
Total liabilitiesDKK 2.08BDKK 3.00BDKK 4.01BDKK 5.24BDKK 4.71B
Shareholders' equityDKK 12.87BDKK 11.41BDKK 10.34BDKK 7.15BDKK 7.37B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full BAVA.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open BAVA.CO financials →